Woodward Diversified Capital, LLC Red Hill Biopharma Ltd. Transaction History

Woodward Diversified Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 28, 2022	SELL	$2.31 - $5.85 $39,475 - $99,970	-17,089 Closed	0 $0
Q3 2021 Nov 04, 2021	SELL	$4.55 - $10.36 $99,144 - $225,744	-21,790 Reduced 56.05%	17,089 $78,000
Q2 2021 Jul 19, 2021	BUY	$5.98 - $7.51 $128,013 - $160,766	21,407 Added 122.52%	38,879 $267,000
Q1 2021 May 17, 2021	BUY	$6.98 - $11.29 $121,954 - $197,258	17,472 New	17,472 $128,000
Q1 2021 May 14, 2021	SELL	$6.98 - $11.29 $160,540 - $259,669	-23,000 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$7.81 - $10.39 $179,630 - $238,970	23,000 New	23,000 $186,000

40.4K

Ticker RDHL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 63,823,500
Market Cap $465M
Description
RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with chronic non-cancer pain; Talicia for the treatment of Helicobacter pylori infection in adults; and Aemcolo for...

Get notified when there are updates to the investment portfolio of Woodward Diversified Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Woodward Diversified Capital, LLC with notifications on news.